Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

First Italian multicentre registry for Mechanically Assisted Circulatory Support (ITAMACS) report: 12-year experience of over 1000 durable LVAD patients.

European journal of heart failure·2026
Same author

From Clinical Heterogeneity to National Standardization in Liver Transplantation for Perihilar Cholangiocarcinoma: The LITALHICA Protocol.

Transplantation·2026
Same author

A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction.

Human reproduction (Oxford, England)·2026
Same author

Is Warm Ischemic Time no Longer an Absolute Cutoff in Organ Donation After Circulatory Determination of Death? The Italian Experience of Prolonged "No-touch" Period.

Transplantation·2026
Same author

Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study.

Frontiers in neurology·2026
Same author

Clinical significance of incidental pericardial late gadolinium enhancement on cardiac magnetic resonance.

International journal of cardiology·2026

相关实验视频

Updated: Jun 9, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

捐赠者的感染风险分层:意大利国家移植中心的活动.

Elena Graziano1, Maddalena Peghin1, Maria Luisa Balsamo1

  • 1Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Varese, Italy.

Transplant infectious disease : an official journal of the Transplantation Society
|November 7, 2025
PubMed
概括

传染病第二意见 (IDSO) 评估接受了近95%的器官捐赠者,扩大了捐赠者池. 需要进行进一步的研究,以评估具有增加感染风险的捐赠者对移植接受者的影响.

关键词:
咨询 咨询 咨询 咨询捐赠 捐赠 是一个捐赠.源于捐赠者的感染.移植传染病的传染病.

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

相关实验视频

Last Updated: Jun 9, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

科学领域:

  • 移植手术 移植手术
  • 传染性疾病 传染性疾病
  • 公共卫生 公共卫生

背景情况:

  • 扩大器官捐赠池对于移植至关重要.
  • 具有感染风险增加的捐赠者需要仔细评估.
  • 意大利国家移植中心 (CNT) 使用专家工作组进行复杂的感染性评估.

研究的目的:

  • 描述传染病第二意见 (IDSO) 工作组的活动.
  • 分析潜在器官捐献者的感染风险评估.
  • 评估IDSO对捐赠池接受度的影响.

主要方法:

  • 从2022年6月到2023年10月的IDSO活动的回顾性观察研究.
  • 根据CNT协议分类的供体感染风险水平的分析.
  • 审查感染问题,风险分类和器官排除原因.

主要成果:

  • 对30%的捐赠者 (1246/4153) 进行了IDSO请求.
  • 大多数捐赠者具有可接受的感染风险增加 (60.8%);只有5.2%被认为是不可接受的.
  • 肺炎,炎症标志物升高和细菌病是常见的传染性问题. 肺是被排斥最多的器官 (18.2%).

结论:

  • IDSO的活动促进了近95%的被评估捐赠者的接受.
  • 对于大量的捐赠者和接受者,提供了额外的测试和治疗指示.
  • 未来的国际研究对于确定从具有增加感染风险的捐赠者接受器官的受体的结果至关重要.